Peer-reviewedCC BYReviews in cardiovascular medicine1 Sep 2026

Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis

Panagiotis Theofilis¹
Paschalis Karakasis²
Panayotis K. Vlachakis¹
Konstantinos Pamporis¹
Aikaterini Vordoni¹
Evangelos Oikonomou³
Kyriakos Dimitriadis¹
Gerasimos Siasos³
Konstantinos Tsioufis¹
Dimitris Tousoulis¹

¹Department of Cardiology, “Hippokration” General Hospital of Athens, 11527 Athens, Greece
²Department of Cardiology, Ippokrateio General Hospital of Thessaloniki, 54642 Thessaloniki, Greece
³Department of Cardiology, Sotiria General Hospital, 11527 Athens, Greece

Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Incident Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Cohort Studies
Disha Disha, Allah Rakhio Bhurgri, Deepak Verma +5
Cureus28 Sep 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMCEurope PMCPMC
Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
Medicine23 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
Shi-ping Sun, Yan Fang, Li Liu +2
Frontiers in medicine16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Prediction Models Versus Fibrosis-4 Index (FIB-4) for Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Verification-Audited Systematic Review and Meta-Analysis
Syed Muhammad Hassan Bukhari, Ushna Shahid, Wahhaj Qayyum +3
Cureus27 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Effectiveness of eHealth lifestyle interventions on management of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
Yangguo Zhao, Xinrui Yang, Yang Bai +2
Nutrition & diabetes1 Jul 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCDOAJ

Cite

BibTeX

@article{theofilis2026metabolic,
  title = {{Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis}},
  author = {Panagiotis Theofilis and Paschalis Karakasis and Panayotis K. Vlachakis and Konstantinos Pamporis and Aikaterini Vordoni and Evangelos Oikonomou and Kyriakos Dimitriadis and Gerasimos Siasos and Konstantinos Tsioufis and Dimitris Tousoulis},
  journal = {Reviews in cardiovascular medicine},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13653178},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis
AU  - Panagiotis Theofilis
AU  - Paschalis Karakasis
AU  - Panayotis K. Vlachakis
AU  - Konstantinos Pamporis
AU  - Aikaterini Vordoni
AU  - Evangelos Oikonomou
AU  - Kyriakos Dimitriadis
AU  - Gerasimos Siasos
AU  - Konstantinos Tsioufis
AU  - Dimitris Tousoulis
PY  - 2026
DA  - 2026/09/01
JO  - Reviews in cardiovascular medicine
UR  - https://europepmc.org/article/PMC/PMC13653178
SN  - 1530-6550
ER  -

Related

Cite